EQS-Ad-hoc: aap Implantate AG / Key word(s): Annual Report aap Implantate AG ("Company") announces that the auditor will no longer complete the audit of the annual and consolidated financial statements for the financial year 2024 in April. As a result, the Company will not be able to publish the annual and consolidated financial statements for 2024 within the statutory deadline of 30 April 2025. The company expects to be able to publish the annual and consolidated financial statements by June 2025. The reason for the delay is a number of details that have arisen in the Group's financial statement process, which can no longer be processed on time due to limited personnel resources. As a result, the company's Annual General Meeting will take place after the publication of the annual and consolidated financial statements for 2024 in summer 2025.
Contact: aap Implantate AG; R. Di Girolamo; Chairman of the Management Board / CEO; Lorenzweg 5; End of Inside Information
29-Apr-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | aap Implantate AG |
Lorenzweg 5 | |
12099 Berlin | |
Germany | |
Phone: | +49 (0) 30 75 019-0 |
Fax: | +49 (0) 30 75 019-111 |
E-mail: | info@aap.de |
Internet: | www.aap.de |
ISIN: | DE000A3H2101 |
WKN: | A3H210 |
Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 2127118 |
End of Announcement | EQS News Service |
|
2127118 29-Apr-2025 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.